Spotlight
Clinical
CME/CE
A Cardiologist’s Perspective on Cardiovascular Risk Assessment in Prostate Cancer
Direct insight from a cardiologist on the advent of cardiovascular risk when treating a patient for prostate cancer.
EP: 1.Cardiovascular Disease Risk in Men with Prostate Cancer
EP: 2.Examining the Data From Key Clinical Trials, and Practical Strategies
EP: 3.Strategies for Mitigating Cardiovascular Risk
EP: 4.Summary and Case Study
EP: 5.A Medical Oncologist Reflects on a Typical Prostate Cancer Patient
EP: 6.A Urologist Reflects on a Typical Prostate Cancer Patient
EP: 7.A Cardiologist Reflects on a Typical Prostate Cancer Patient
EP: 8.Practice-Related And Provider-Patient Communication Strategies For Prostate Cancer Care
Now Viewing
EP: 9.A Cardiologist’s Perspective on Cardiovascular Risk Assessment in Prostate Cancer
EP: 10.A Medical Oncologist’s Perspective on Cardiovascular Risk Assessment in Prostate Cancer
EP: 11.Typical Examinations And Tests For Cardiovascular Risk Assessment in a Cardiology Practice
EP: 12.Typical Examinations And Tests For Cardiovascular Risk Assessment in an Oncology Practice
EP: 13.A Cardiologist’s Recommended Interventions For Cardiovascular Risk Mitigation
EP: 14.A Medical Oncologist’s Recommended Interventions For CV Risk Mitigation
EP: 15.Strategies For Communicating Cardiovascular Risk to Patients Starting on ADT
EP: 16.Considerations For ADT Selection And Patient Education on Treatment-Related AEs
EP: 17.A Urologist’s Approach to Followup For Patients on ADT And Practice Communication Strategies
EP: 18.A Cardiologist’s Approach to Followup For Patients on ADT and Strategies in Multidisciplinary Care
EP: 19.A Urologist Reacts to AbbVie’s Educational Video: Key Takeaways And Clinical Impact
EP: 20.A Cardiologist Reacts to AbbVie’s Educational Video: Key Takeaways And Clinical Impact
January 2023 AbbVie Inc. Company Confidential
Related Videos
